Pamela Haley
2021
In 2021, Pamela Haley earned a total compensation of $474.4K as Chief Financial Officer at Arcadia Biosciences, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $10,080 |
|---|---|
| Option Awards | $224,336 |
| Salary | $240,000 |
| Total | $474,416 |
Haley received $240K in salary, accounting for 51% of the total pay in 2021.
Haley also received $10.1K in non-equity incentive plan and $224.3K in option awards.
Rankings
In 2021, Pamela Haley's compensation ranked 10,824th out of 12,405 executives tracked by ExecPay. In other words, Haley earned more than 12.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,824 out of 12,405 | 13th |
Division Agriculture, Forestry, And Fishing | 51 out of 66 | 23rd |
Major group Agricultural Production Crops | 36 out of 45 | 20th |
Source: SEC filing on April 19, 2022.
Haley's colleagues
We found three more compensation records of executives who worked with Pamela Haley at Arcadia Biosciences in 2021.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019